Katell Bidet Huang is the head of Translational Medicine at Transgene, where she focuses on characterizing the immune responses after treatment with viral-vectored individualized cancer vaccine and oncolytic viruses. She has a scientific background in virology and immunology and a particular interest in understanding how and why patients respond to therapy. Prior to Transgene, she… Continue reading Katell Bidet-Huang
Category: tools-profils-members
Anne Stehlin
Anne Stehlin, PharmD, recently joined Transgene as Chief Quality Officer and Responsible Pharmacist. Dr. Stehlin is a pharmaceutical executive with extensive experience in quality and manufacturing operations. Prior to joining Transgene, she held senior global quality leadership roles at Lonza, a leading biopharmaceutical CDMO. Before that, she served as Head of Global Quality Management and… Continue reading Anne Stehlin
Dorothea Ledergerber
Dorothea Ledergerber currently serves as Multi-Site Head of Drug Product Operations at Siegfried Group and is also a member of the Board of Directors of the CDMO DINAMIQS. A trained pharmacist with a PhD in pharmaceutical sciences, she brings over 25 years of experience in the pharmaceutical and biotechnology industries. She previously held leadership roles… Continue reading Dorothea Ledergerber
Solange Peters
Solange Peters is a Swiss medical oncologist and Professor, Head of Oncology, and Chair of Medical Oncology at the Lausanne University Hospital (CHUV). Trained in Switzerland and Italy, she specializes in thoracic oncology, particularly lung and pleural cancers. Her research focuses on biomarker discovery, multimodal strategies for locally advanced non-small cell lung cancer, and cancer… Continue reading Solange Peters
Sandrine LEMIUS
Sandrine Lemius was appointed in 2026 as Deputy CEO – Responsible Pharmacist ad interim during the transition period between the retirement of Mr. Christophe Ancel and the hiring of his successor. She has held the position of Head of Regulatory Affairs since February 2025 and has also served as Interim Responsible Pharmacist since December 2015. She… Continue reading Sandrine LEMIUS
Fériel MARIN
Fériel Marin was appointed in 2026 as Chief Quality Officer ad interim to ensure continuity during the transition between the retirement of Mr. Christophe Ancel, the current Quality Director, and the arrival of the Company’s new Quality Director. An engineer by training and a graduate of the Strasbourg School of Management, she began her career in… Continue reading Fériel MARIN
Sabine Tejpar
Sabine Tejpar, MD, is blablabla
Ignacio Melero
Ignacio Melero , MD, PhD, is a full professor of immunology at the University of Navarra and co-director of the Department of Immunology and Immunotherapy at the Clínica Universidad de Navarra. He is widely recognized for his pioneering work in cancer immunotherapy, particularly on immunostimulatory monoclonal antibodies and co-stimulation of antitumor immune responses. He spent… Continue reading Ignacio Melero
Antoine Italiano
Antoine Italiano , MD, PhD, is a renowned medical oncologist specializing in early drug development and precision medicine. He serves as Head of the Department of Medicine at Institut Bergonié in Bordeaux and leads the Precision Medicine program at Gustave Roussy in Paris. Prof. Italiano has been the Principal Investigator for over 50 Phase I… Continue reading Antoine Italiano
Fatima Cardoso
Fatima Cardoso, MD, is blablabla